Endogenous cannabinoids: A new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat
- 1 January 2002
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 122 (1) , 85-93
- https://doi.org/10.1053/gast.2002.30305
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- SR141716A, a potent and selective antagonist of the brain cannabinoid receptorPublished by Wiley ,2001
- Nitric Oxide as a Mediator of Hemodynamic Abnormalities and Sodium and Water Retention in CirrhosisNew England Journal of Medicine, 1998
- Platelet‐ and macrophage‐derived endogenous cannabinoids are involved in endotoxin‐induced hypotensionThe FASEB Journal, 1998
- ‘Endocannabinoids’ and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevanceBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1998
- CANNABINOID RECEPTORS AND THEIR ENDOGENOUS AGONISTSAnnual Review of Pharmacology and Toxicology, 1998
- Endocannabinoids: a new class of vasoactive substancesTrends in Pharmacological Sciences, 1998
- Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shockNature, 1997
- Cardiovascular Effects of Anandamide in Anesthetized and Conscious Normotensive and Hypertensive RatsHypertension, 1997
- Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamideEuropean Journal of Pharmacology, 1995
- Pathogenesis of arterial hypotension in cirrhotic rats with ascites: Role of endogenous nitric oxideHepatology, 1992